What is the appropriate management for a patient with drug‑induced oral mucosal pain and burning that persists despite treatment with fluticasone propionate ointment?

Management of Drug-Induced Oral Mucosal Pain Unresponsive to Fluticasone Propionate

Stop the fluticasone propionate ointment immediately and escalate to topical high-potency corticosteroids—specifically dexamethasone mouth rinse (0.1 mg/ml) for widespread lesions or clobetasol gel/ointment (0.05%) for localized ulcers—while implementing comprehensive pain management with topical anesthetics and systemic analgesics. 1

Critical First Step: Identify and Remove the Offending Drug

The persistence of symptoms despite fluticasone treatment strongly suggests ongoing drug exposure. Drug-induced oral ulcerations typically resist conventional treatments but heal rapidly once the causative agent is discontinued 2. Key diagnostic clues include:

• Symptoms of burning mouth, metallic taste, dysgeusia, or ageusia preceding ulceration 2
• Recent medication changes (within weeks of symptom onset) 2
• Recurrent lesions at the same site with repeated drug exposure 3

Common culprits include:

• NSAIDs (diclofenac, flurbiprofen, indomethacin, naproxen)
• ACE inhibitors (captopril, enalapril)
• Antidepressants (fluoxetine, lithium)
• Disease-modifying antirheumatic drugs (methotrexate, azathioprine, penicillamine)
• Angiotensin-2 receptor antagonists (losartan)
• Anti-anginal agents (nicorandil) 2

Why Fluticasone Propionate Ointment Is Inadequate

Important caveat: The FDA-labeled fluticasone propionate is formulated as a nasal spray for allergic rhinitis, not as an oral ointment 4. If fluticasone propionate ointment is being used off-label for oral mucosa, it likely lacks sufficient potency for drug-induced oral ulceration. The ESMO guidelines specifically recommend high-potency topical corticosteroids for oral mucosal injury, not medium-potency formulations 1.

Escalated Treatment Algorithm

Step 1: Topical High-Potency Corticosteroids (First-Line)

For multiple or difficult-to-reach ulcerations:

• Dexamethasone mouth rinse 0.1 mg/ml
• Rinse for ~1 minute, 4-6 times daily
• Do not eat or drink for 30 minutes after rinsing 1

For limited, easily accessible ulcers:

• Clobetasol gel or ointment 0.05%
• Apply directly to lesions 1

Step 2: Aggressive Pain Management (Concurrent)

Immediate relief:

• Viscous lidocaine 2% mouthwash before meals and as needed 1
• Coating agents (e.g., sucralfate suspension, though not for prevention) 1

Moderate pain:

• Topical NSAID: amlexanox 5% oral paste applied to lesions 1
• If NSAIDs contraindicated: acetaminophen as maintenance therapy 1

Severe persistent pain:

• Immediate-release oral opioid or fast-acting fentanyl preparation (50 μg fentanyl nasal spray) for breakthrough pain, especially before meals 1
• Consider transdermal or intranasal routes if oral administration is too painful 1

Step 3: Supportive Oral Care Protocol

Critical modifications for drug-induced injury:

• Use sodium bicarbonate-containing mouthwash (not plain water) 4-6 times daily, increasing to hourly if needed 1
• Maintain optimal nutrition throughout treatment 1
• Brush with soft toothbrush after meals and before sleep 1
• Use alcohol-free, non-foaming mouthwash 1

Avoid painful stimuli:

• Smoking, alcohol
• Citrus fruits, tomatoes, spicy/hot/crusty foods 1

Step 4: If No Resolution After 1-2 Weeks

Intralesional steroid injection:

• Triamcinolone weekly (total dose 28 mg) in conjunction with topical clobetasol 1

Systemic corticosteroids (for highly symptomatic or recurrent ulcers):

• High-dose pulse: 30-60 mg or 1 mg/kg oral prednisone/prednisolone for 1 week
• Taper dose over second week 1

Essential Monitoring and Red Flags

Rule out secondary infection:

• Drug-induced oral injury increases infection risk (38% of patients with targeted therapy show infection at sites of mucosal injury) 1
• Common pathogens: Staphylococcus aureus (22.6%), herpes simplex (3.2%), Candida 1
• If thick discharge, worsening pain, or fever develop, culture and treat appropriately

When to refer urgently:

• No improvement after 2 weeks of escalated therapy
• Suspicion of malignancy (obtain biopsy) 5
• Severe dysphagia or inability to maintain nutrition
• Signs of systemic drug reaction (skin involvement, fever, lymphadenopathy) 6

Common Pitfalls to Avoid

1. Continuing the offending medication while treating symptoms—this guarantees treatment failure 2
2. Using medium-potency topical steroids (like fluticasone) when high-potency formulations are required 1
3. Inadequate pain control leading to nutritional compromise and reduced quality of life 1
4. Missing secondary infections that complicate drug-induced injury 1
5. Failing to obtain detailed drug history, including over-the-counter medications and supplements 2, 3

Expected Timeline

• With appropriate management: Complete resolution typically occurs within 2-4 weeks after discontinuing the offending drug 5, 2
• Symptom recurrence upon drug re-exposure confirms the diagnosis 2, 3
• Persistent symptoms beyond 4 weeks warrant biopsy to exclude other pathology 5